Edge Pharmaceutical Group
Committed to Medicine
The Edge Pharmaceutical Group is a privately owned global pharmaceutical company, centred around strategic affiliations in key markets and with a strong heritage in the development, manufacturing, registration, and supply of healthcare products.
Message from the Boardroom
“We are committed to our partners around the globe, assuring a personal approach to the ethical supply of our products which are supported by the scientific efficacy as well as the world-class commercial and technical expertise we provide at Edge”
Products
Edge provides a broad range of affordable generic medicines, as well as carefully selected biosimilars and consumer health products to our partners on B2B basis across the globe. Our Intellectual Property is available through a variety of business models including:
- License & Supply Agreements
- Exclusive Distribution Agreements
- Asset Swaps
- Risk Share Agreements
- Co-development contributions
- Acquisitions and Divestments
- Any other commercial opportunity
Services
Through our collaborative approach and expertise Edge is proud to offer a comprehensive set of value-added activities and services:
- API Sourcing
- Research and Development Expertise
- Portfolio Management
- Business Development
- Regulatory Affairs
- Pharmacovigilance
- Quality Control Services
- Batch Release
- Third Party Audits
- Supply Chain Management activities
